Current perspectives on surgical treatment and prognostic factors for recurrence of eyelid skin cancer
Vol. 69 No. 3 (2023), REVIEWS
Vol. 69 No. 3 (2023)

Current perspectives on surgical treatment and prognostic factors for recurrence of eyelid skin cancer

REVIEWS
https://doi.org/10.37469/0507-3758-2023-69-3-389-398
Published 30.06.2023

Кафедра онкологии, лучевой диагностики и лучевой терапии ГОУ ТГМУ им. Абуали ибни Сино
https://orcid.org/0000-0002-4311-3094
Zafar Huseynzoda
ГУ «Республиканский онкологический научный центр» Министерство здравоохранения и социальной защиты населения Республики Таджикистан
https://orcid.org/0000-0002-4823-8531
Shamsiddin Nazarov
Республиканский онкологический научный центр. г. Душанбе
https://orcid.org/0000-0002-5829-8431
Lola Makhmudova
ГУ «Республиканский онкологический научный центр» Министерство здравоохранения и социальной защиты населения Республики Таджикистан
https://orcid.org/0000-0003-2343-2036
Ilhomidin Niyazov
ТГМУ им. Абуали ибни Сино
https://orcid.org/0000-0002-2361-043X
##article.numberofdownloads## 121
##article.numberofviews## 112
pdf (Русский)

Keywords

basal cell and squamous cell skin cancer of the eyelids
surgical treatment
reconstructive surgery
prognostic factors

How to Cite

Sanginov, D., Huseynzoda, Z., Nazarov, S., Makhmudova, L., & Niyazov , I. (2023). Current perspectives on surgical treatment and prognostic factors for recurrence of eyelid skin cancer . Voprosy Onkologii, 69(3), 389–398. https://doi.org/10.37469/0507-3758-2023-69-3-389-398
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

The article provides a detailed review of national and foreign literature on modern methods of diagnosis and treatment of cancer of the eyelids. A study of scientific platforms Medline, Scopus, e-Library and Web of Science was carried out. The review discusses the features of the course and options for surgical treatment of the disease, based on clinical and morphological subtypes, prevalence, localization of the tumor in relation to the organ of vision, postoperative defects, as well as previous treatment methods, and stratified prognostic factors. At the same time, the large size, thickness or depth of the tumor, poor histological differentiation, perineural invasion of the tumor and the immunosuppressive status of patients are attributed to factors that increase the risk of local recurrence. The existing methods of plastic and reconstructive methods of surgical treatment and indications for their use are described in detail, with a discussion of the advantages and disadvantages of each of them.

Keywords: basal cell and squamous cell skin cancer of the eyelids, surgical treatment, reconstructive surgery, prognostic factors.

https://doi.org/10.37469/0507-3758-2023-69-3-389-398
##article.numberofdownloads## 121
##article.numberofviews## 112
pdf (Русский)

References

Al Wohaib M, Al Ahmadi R, Al Essa D, et al. Characteristics and factors related to eyelid basal cell carcinoma in Saudi Arabia. Middle East Afr J Ophthalmol. 2018;25(2):96102. doi:10.4103/meajo.MEAJO_305_17.

Голованова М.А., Саакян С.В., Денисенко А.Н. Эпидемиология офтальмоонкологических заболеваний взрослого населения Нижегородской области. Опухоли головы и шеи. 2019;9(4):4348 [Golovanova MA, Saakyan SV, Denisenko AN. Epidemiology of ophthalmooncology among the adult population of the Nizhny Novgorod Region. Head and Neck Tumors (HNT). 2020;9(4):43–8 (In Russ.)]. doi:10.17650/2222-1468-2019-9-4-43-48.

Madge SN, Khine AA, Thaller VT, et al. Globe-sparing surgery for medial canthal Basal cell carcinoma with anterior orbital invasion. Ophthalmology. 2010;117(11):22228. doi:10.1016/j.ophtha.2010.02.013.

Bohnak CE, Dempsey KS, Harmsen HJ, et al. Mucoepidermoid carcinoma of the eyelid in an adolescent. Ophthalmic Plast Reconstr Surg. 2022;38(3):307309. doi:10.1097/IOP.0000000000002083.

Гришина Н.И., Нам В.А. Радиохирургическое лечение опухолей век. Саратовский научно-медицинский журнал. 2021;17(3):632635 [Grishina NI, Nam VA. Radiosurgical treatment of eyelid tumors. Saratov Journal of Medical Scientific Research 2021;17(3):6325 (In Russ.)].

Mercut R, Mercut IM, Glodeanu AD, et al. Eyelid carcinomas: Tumor aggressiveness tendencies for smokers compared to non-smokers. Exp Ther Med. 2022;23(3):234. doi:10.3892/etm.2022.11159.

Ding S, Sagiv O, Guo Y, et al. Change in eyelid carcinoma t category with use of the 8th versus 7th edition of the American Joint Committee on Cancer: Cancer staging manual. Ophthalmic Plast Reconstr Surg. 2019;35(1):3841. doi:10.1097/IOP.0000000000001133.

Yunoki T, Hayashi A, Oiwake T, et al. Efficacy and safety of cryotherapy for residual tarsus and free tarsal graft implantation after excision of malignant eyelid tumor. Journal of Craniofacial Surgery. 2022;33(6):e598–601. doi:10.1097/scs.0000000000008681.

Shimizu N, Oshitari T, Yotsukura J, et al. Ten-year epidemiological study of ocular and orbital tumors in Chiba University Hospital. BMC Ophthalmol. 2021;21(1):344. doi:10.1186/s12886-021-02108-w.

Lemaître S, Lévy-Gabriel C, Desjardins L, et al. Outcomes after surgical resection of lower eyelid tumors and reconstruction using a nasal chondromucosal graft and an upper eyelid myocutaneous flap. J Fr Ophtalmol. 2018;41(5):412420. doi:10.1016/j.jfo.2017.10.008.

Гришина Е.Е., Бондаренко Е.В., Богатырев А.М. Аденокарцинома сальной железы века. Точка зрения. Восток-Запад. 2021;3:100103 [Grishina EE, Bondarenko EV, Bogatyrev AM. Adenocarcinoma of the meibomian gland. Point of View East-West. 2021;(3):100103 (In Russ.)].

Панова И.Е., Аракелян А.Э., Кученкова И.А. К вопросу рецидивирующего течения злокачественных новообразований кожи век. Опухоли головы и шеи. 2016;4:2629 [Panova IE, Arakelyan AE, Kuchenkova IA. Recurrent malignant tumors of the eyelid. Head and neck tumors (HNT). 2016;6(4):26–9 (In Russ.)]. doi:10.17650/2222-1468-2016-6-4-26-29.

Akhlaghdoust M, Safari S, Davoodi P, et al. The relation between eyelid tumors and demographic variable. Journal of Ophthalmology. 2021;93(4):57–60. doi:10.31288/oftalmolzh202145760.

Бочкарева А.Н. и др. Повышение эффективности лечения злокачественных новообразований век. Здравоохранение Дальнего Востока. 2020;2:3639 [Bochkareva AN, et al. Improving the effectiveness of treatment for malignant eyelid neoplasms. Public Health of the Far East. 2020;(2):3639 (In Russ.)].

Kaliki S, Pyda S, Goel N, et al. Malignant eyelid tumors: Are intra-operative rapid frozen section and permanent section diagnoses of surgical margins concordant? Int Ophthalmol. 2019;39(10):22052211. doi:10.1007/s10792-018-1058-0.

North VS, Habib LA, Yoon MK. Merkel cell carcinoma of the eyelid: A review. Surv Ophthalmol. 2019;64(5):659667. doi:10.1016/j.survophthal.2019.03.002.

Herwig-Carl MC, Löffler KU. Lidtumoren: Klinische Aspekte der Ophthalmopathologie [Eyelid tumors: Clinical aspects of ophthalmic pathology]. Klin Monbl Augenheilkd. 2018;235(7):776781. doi:10.1055/a-0633-3120.

Watanabe A, Sun MT, Pirbhai A, et al. Sebaceous carcinoma in Japanese patients: clinical presentation, staging and outcomes. Br J Ophthalmol. 2013;97(11):145963. doi:10.1136/bjophthalmol-2013-303758.

Esmaeli B, Nasser QJ, Cruz H, et al. American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. Ophthalmology. 2012;119(5):107882. doi:10.1016/j.ophtha.2011.11.006.

Mandal SK, Majumdar B, Ganguly P, et al. Total or subtotal replacement of tarsal plate by novel silicone plate for upper eyelid reconstruction in malignant tumors. Indian J Ophthalmol. 2021;69(10):27882795. doi:10.4103/ijo.IJO_2822_20.

Monheit G, Hrynewycz K. Mohs surgery for periocular tumors. Dermatol Surg. 2019;45(Suppl 2):S70S78. doi:10.1097/DSS.0000000000002254.

Clarke P. Nonmelanoma skin cancers - treatment options. Aust Fam Physician. 2012;41(7):47680.

Hirayama M, Kawakita T, Tsubota K, et al. Challenges and strategies for regenerating the lacrimal gland. Ocul Surf. 2016;14(2):13543. doi:10.1016/j.jtos.2015.11.005.

Юдаков А.В., Милюдин Е.С. Взгляды на методы реконструктивной хирургии век при удалении новообразований. Практическая медицина. 2017;1(9(110)):192196 [Yudakov AV, Milyudin ES. Views on reconstructive eyelid surgery methods during tumor removal. Practical Medicine. 2017;1(9(110)):192196 (In Russ.)].

Williams NM, Navarrete-Dechent C, Marghoob AA, et al. Differentiating basal cell carcinoma from intradermal nevi along the eyelid margin with dermoscopy: A case series. J Am Acad Dermatol. 2021;84(1):173175. doi:10.1016/j.jaad.2020.04.059.

Altuntas Z, Uyar I, Findik S. Our clinical experiences in lower eyelid reconstruction. Turkish Journal of Plastic Surgery. 2018;26(1):2. doi:10.4103/tjps.tjps_16_18.

Zhang J, Sisley AM, Anderson AJ, et al. Characterization of a novel collagen scaffold for corneal tissue engineering. Tissue Eng Part C Methods. 2016;22(2):165172. doi:10.1089/ten.TEC.2015.0304.

Sun MT, Wu A, Huilgol SC, et al. Accuracy of biopsy in subtyping periocular basal cell carcinoma. Ophthalmic Plast Reconstr Surg. 2015;31(6):44951. doi:10.1097/IOP.0000000000000372.

Iuliano A, Strianese D, Uccello G, et al. Risk factors for orbital exenteration in periocular Basal cell carcinoma. Am J Ophthalmol. 2012;153(2):238241.e1. doi:10.1016/j.ajo.2011.08.004.

Груша Я.О., Ризопулу Э.Ф. Реконструкция век с использованием надкостничного лоскута. Всероссийская школа офтальмолога. 2016:6365 [Grusha YaO, Rizopulu EF. Eyelid reconstruction using periosteal flaps. In: XV All-Russian Ophthalmologist School. 2016:6365 (In Russ.)].

Yin VT, Pfeiffer ML, Esmaeli B. Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Reconstr Surg. 2013;29(2):87–92. doi:10.1097/iop.0b013e3182831bf3.

Haagdorens M, Van Acker SI, Van Gerwen V, et al. Limbal stem cell deficiency: Current treatment options and emerging therapies. Stem Cells Int. 2016;2016:9798374. doi:10.1155/2016/9798374.

Jordan DR, Tse DT, Anderson RL, et al. Irradiated homologous tarsal plate banking: a new alternative in eyelid reconstruction. Part II. Human data. Ophthalmic Plast Reconstr Surg. 1990;6(3):16876.

Liao SL, Wei YH. Correction of lower lid retraction using tarSys bioengineered grafts for graves ophthalmopathy. Am J Ophthalmol. 2013;156(2):387392.e1. doi:10.1016/j.ajo.2013.03.017.

eSousa JL, Malhotra R, Davis G. Sliding tarsal flap for reconstruction of large, shallow lower eyelid tarsal defects. Ophthalmic Plast Reconstr Surg. 2007;23(1):468. doi:10.1097/IOP.0b013e31802dd415.

Morley AM, deSousa JL, Selva D, et al. Techniques of upper eyelid reconstruction. Surv Ophthalmol. 2010;55(3):25671. doi:10.1016/j.survophthal.2009.10.004.

Irawati Y, Paramita C, Daniel H. Challenging eyelid reconstruction in malignancies: Case reports. Ann Med Surg (Lond). 2021;71:102987. doi:10.1016/j.amsu.2021.102987.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2023